$CAT Short Iron Condor: Cost $0 (Net Credit $295), Max Profit $295 in 9 Days
$Caterpillar(CAT)$ Options Short Iron Condor: Credit $295, Max Profit $295 on Apr 8, 2026 📊 Ticker: $CAT Strategy: Short Iron Condor Contracts: Sell to Open: CAT Apr 17 $740 Call Buy to Open: CAT Apr 17 $750 Call Sell to Open: CAT Apr 17 $710 Put Buy to Open: CAT Apr 17 $700 Put Cost: $295 Max Gain: $295 (100% of premium if stock stays between $710-$740) Max Loss: $705 (if stock moves outside the wings) Profit Zone: $700 - $710 to $740 - $750 Thesis: Neutral to range-bound view on Caterpillar. Earnings volatility has likely compressed, expecting the stock to chop sideways through April expiration. Collecting premium from both sides while defining risk outside the expected move. Happy if it stays in the middle—max pain is a big breakout in either di
$INTC Bull Call Spread Strategy — Cost $32, Max Profit Up to $200,
$Intel(INTC)$ Options Bull Call Spread: Cost $650, Max Profit $850 on Apr 8, 2026 📊 Ticker: $INTC Strategy: Bull Call Spread Contracts: Buy to Open: INTC Oct 20 $30 Call Sell to Open: INTC Oct 20 $45 Call Cost: $650 Max Gain: $850 (1.3x return) Max Loss: $650 (100% of premium) Breakeven: $36.50 Thesis: Moderately bullish on Intel with a wide spread capturing upside toward $45. Legacy chip maker with foundry ambitions—playing for a sentiment shift while the turnaround narrative plays out. Wide strikes offer attractive risk/reward if momentum builds, with max loss capped if the story fizzles. ⚠️ Disclaimer: This is not financial advice. Options trading involves significant risk and may result in loss of capital. Past performance does not guarantee f
$AVGO Iron Condor Strategy — Cost $190, Max Profit $310 in 2 Days
$Broadcom(AVGO)$ Options Bull Call Spread: Cost $320, Max Profit $180 on Apr 8, 2026 📊 Ticker: $AVGO Strategy: Bull Call Spread Contracts: Buy to Open: AVGO Apr 10 $330 Call Sell to Open: AVGO Apr 10 $335 Call Cost: $320 Max Gain: $180 (0.56x return) Max Loss: $320 (100% of premium) Thesis: Moderately bullish on Broadcom into next week's expiration. AI and data center demand continue to drive semiconductor names. Playing for a move toward $335 with defined risk—if it expires above the short strike, capture the spread width. If it stalls, premium is the tuition. ⚠️ Disclaimer: This is not financial advice. Options trading involves significant risk and may result in loss of capital. Past performance does not guarantee future results. Always do your
$AVGO Iron Condor Strategy — Cost $190, Max Profit $310 in 2 Days
$Broadcom(AVGO)$ Options Bull Call Spread: Cost $320, Max Profit $180 on Apr 8, 2026 📊 Ticker: $AVGO Strategy: Bull Call Spread Contracts: Buy to Open: AVGO Apr 10 $330 Call Sell to Open: AVGO Apr 10 $335 Call Cost: $320 Max Gain: $180 (0.56x return) Max Loss: $320 (100% of premium) Thesis: Moderately bullish on Broadcom into next week's expiration. AI and data center demand continue to drive semiconductor names. Playing for a move toward $335 with defined risk—if it expires above the short strike, capture the spread width. If it stalls, premium is the tuition. ⚠️ Disclaimer: This is not financial advice. Options trading involves significant risk and may result in loss of capital. Past performance does not guarantee future results. Always do your
$CVS Bear Put Spread: $104 Cost, Earn Up to $146 by Apr 17 (9 DTE)
$CVS Health(CVS)$ Options Bear Put Spread: Cost $104, Max Profit $146 on Apr 8, 2026 📊 Ticker: $CVS Strategy: Bear Put Spread (Debit Spread) Contracts: Buy to Open: CVS Apr 17 $77.5 Put Sell to Open: CVS Apr 17 $75 Put Cost: $104 Max Gain: $146 (1.4x return) Max Loss: $104 (100% of premium) Thesis: Mildly bearish on CVS near-term. Healthcare retail facing margin pressures and regulatory headwinds. Defined risk play—if it breaks below $75, the spread maxes out. If wrong, premium lost is capped. ⚠️ Disclaimer: This is not financial advice. Options trading involves significant risk and may result in loss of capital. Past performance does not guarantee future results. Always do your own research and consult a qualified financial advisor before making i
$UNH Options Bull Put Spread: Credit $95, Max Profit $95 on Apr 8, 2026
📊 Ticker: $UnitedHealth(UNH)$ Strategy: Bull Put Spread (Credit Spread) Contracts: Sell to Open: UNH Apr 18 $300 Put Buy to Open: UNH Apr 18 $295 Put Credit: $95 Max Gain: $95 (100% of premium if expires worthless) Max Loss: $405 (strike width minus credit) Thesis: Neutral to moderately bullish on UnitedHealth into April expiration. Selling 2-week premium while defining downside risk. Happy to pocket the credit if stock stays above $300, ready to defend if it doesn't. ⚠️ Disclaimer: This is not financial advice. Options trading involves significant risk and may result in loss of capital. Past performance does not guarantee future results. Always do your own research and consult a qualified financial advisor before making investment decisions.
$NVDA Iron Condor: Cost $167, Max Profit $83 in 2 Days
$NVIDIA(NVDA)$ Options Bull Call Spread: Cost $750, Max Profit $1,250 on Apr 8, 2026 📊 Ticker: $NVDA Strategy: Bull Call Spread Contracts: Buy to Open: NVDA May 17 $900 Call Sell to Open: NVDA May 17 $920 Call Cost: $750 Max Gain: $1,250 (1.67x return) Max Loss: $750 (100% of premium) Breakeven: $907.50 Thesis: Bullish on NVIDIA into May expiration. AI infrastructure demand remains relentless, and this spread captures a move toward $920 while keeping risk defined. Wide strikes offer attractive upside if momentum builds—don't need NVDA to hit new highs, just a grind higher through the summer months. ⚠️ Disclaimer: This is not financial advice. Options trading involves significant risk and may result in loss of capital. Past performance does not gua
$PSKY Options Bull Call Spread: Cost $33, Max Profit $200 on Apr 8, 2026
📊 Ticker: $Paramount Skydance Corp(PSKY)$ Strategy: Short Iron Condor Contracts: Sell to Open: PSKY Apr 17 $11 Call Buy to Open: PSKY Apr 17 $12 Call Sell to Open: PSKY Apr 17 $10 Put Buy to Open: PSKY Apr 17 $9 Put COST : $33 Max Gain: $33 (100% of premium if stock stays between $10-$11) Max Loss: $67 (if stock moves outside the wings) Profit Zone: $10 - $11 Thesis: Neutral to range-bound view on PSKY into April expiration. Expecting the stock to consolidate within the $9-$12 range through expiration. Selling premium on both sides while defining tight risk—ideal for a low-volatility environment where the underlying chops sideways. Max pain is a breakout above $12 or breakdown below $9. ⚠️ Disclaimer: This is not financial advice. Options trading
DBS at $57.63 and 4.59% Yield | SGX Daily Pulse 07 Apr 2026 | 🦖EP1532
DBS at $57.63 and 4.59% Yield | SGX Daily Pulse 07 Apr 2026 | 🦖EP1532The STI is flirting with 5,000 because the market sees recovery, but my spreadsheet sees S$178m of Air India losses, 38.7% gearing at “infrastructure” trusts, and US REITs sitting at 45.0% leverage one bad valuation away from a cash call. When DBS prints a 4.59% yield, SIA is loved for load factors, and Del Monte is still trading with negative US$618m equity plus an auditor disclaimer, I cannot pretend these are harmless “income” positions in a CPF or SRS account. My stance is simple: if the cash flow is funding someone else’s restructuring, it has no business being labelled retirement‑grade.In a 5,000‑point STI world, the benchmark is not your neighbour’s portfolio, it is the 1.37–1.46% Singapore T‑Bill and a hard 3.2% F
The question cuts to the core: is this a blip, or a regime shift? --- 1. JPM’s call: extreme, but not random The ~$145 target implies: Tesla trades like a normal auto company, not a tech platform Margins compress + growth slows materially AI/robotaxi premium gets discounted That is a full de-rating thesis, not just a bad quarter. --- 2. What the Q1 miss is really signalling The numbers matter less than the pattern: Inventory +50k units → supply > demand Deliveries miss despite production strength Price cuts already exhausted in many regions This is not just logistics noise. It suggests: > Demand elasticity is weakening at current price points --- 3. The real debate: two Teslas Bull case (what market still prices) Not a car company, but an AI + autonomy platform Robotaxi, Optimus, FSD
$INCANNEX HEALTHCARE LTD(IXHL)$ IXHL is one of the clearest examples of why small-cap biotech stocks can destroy investor trust. The biggest problem is dilution risk. In March 2026, Incannex announced a US$10 million registered direct offering priced at US$5.00 per share with accompanying warrants, and it also expanded its sales-agreement capacity by another US$50 million of common stock issuance. For existing shareholders, that creates a heavy overhang and makes it hard to feel protected. The business is still highly speculative. In its quarterly reporting, the company said it generated no revenue for the December 2025 quarter and does not expect material revenue unless and until its drug candidates are approved. It also reported continuing oper
$Plug Power(PLUG)$ $10 Target Price Positive Catalysts for PLUG Growth 1. Major Electrolyzer Project Win with Hy2gen: Event: On April 2, 2026, PLUG was selected to supply a 275 MW Geneco electrolyzer system to Hy2gen's Courant decarbonized ammonia project in Canada. Catalyst Impact: This is a significant, large-scale industrial project that validates PLUG's technology in the green hydrogen space. It represents substantial future
I still remember last April clearly — when tariff headlines triggered a waterfall selloff. What I learned is simple: panic-selling is usually the worst move. When $S&P 500(.SPX)$ and $NASDAQ(.IXIC)$ crashed, the rebound came just days later. That taught me to stay disciplined and not get shaken out at the bottom. Going into tonight, I’m staying cautious. With $FUT:WTI Crude Oil - main 2604(CLmain)$ already elevated, the setup feels very binary. I’m not chasing — just holding some cash and keeping hedges on. For me, capital preservation matters more than trying to perfectly call the move. Liquidity and flexibility are my priority here. I think the mark
I find both strategies interesting, but I wouldn’t take the “100% win rate” literally. CNBC’s “Markets in Turmoil” makes sense psychologically — extreme fear often marks a bottom — but it’s based on limited historical context. Similarly, the $S&P 500(.SPX)$ being higher a year later reflects long-term upward bias, not a guaranteed signal. The $Cboe Volatility Index(VIX)$ 35/15 rule feels more practical since it measures market sentiment. High VIX shows panic, low VIX shows complacency, but I see it as a guideline rather than a strict rule — markets can stay fearful or calm longer than expected. I wouldn’t rely on t
$United States Oil Fund LP(USO)$$S&P 500(.SPX)$ $Texas Oil Index ETF(OILT)$ 🔥🛢️⚠️ $USOIL Regime Shift: $USO Captures Structural Breakout as Physical Scarcity and Geopolitical Convexity Collide 📈🌍🚨 Crude oil is no longer in a rally. It is repricing into a new regime. WTI is holding $114–$115, its highest level since Jun22 and now within range of the $129.42 cycle high. What matters to me is not just the level, but the structure. Futures, physical markets, and systematic flows are all confirming the move simultaneously. I’m analysing this through three converging forces. Momentum, physical tightness, and convex geopolitical risk. 📊 Systema
$Invesco QQQ(QQQ)$$SPDR S&P 500 ETF Trust(SPY)$ $S&P 500(.SPX)$ 📊📉📊 $QQQ Mixed Gamma Regime Tightens as $4.8M Bearish Flow Builds While $SPY Trades Inside Institutional Liquidity Corridor 📊📉📊 $QQQ is now firmly embedded in a mixed gamma regime, where near-term dealer support masks a more fragile underlying structure. Short-dated positioning continues to dampen realised volatility, effectively pinning price action. However, the distribution of longer-dated negative gamma introduces latent instability, meaning any displacement move has the potential to accelerate non-linearly. I’m seeing a clear bifurcation in dealer behaviour, stable a
🌟🌟🌟Singapore inflation is like that one relative who keeps showing up uninvited, persistent, annoying & unwanted. Yes CDC vouchers do help a little bit let's be honest: they are like Panadol for a headache. They are comforting, useful but not enough when chicken rice hits $10 & Kopi is $5! But here is the twist: Even as everything gets pricier, the Singapore market quietly rewards those who stay invested, not those who panic every time oil spikes or headlines scream. I will continue to stay invested especially in our local banks $DBS(D05.SI)$ $OCBC Bank(O39.
Why Kimly Is My Micro Cap Moonshot 🌟🌟🌟In a world obsessed with AI software and geopolitical drama, sometimes the biggest home runs are hidden in plain sight. While the market waits for Trump's Deadline for Iran, I am looking at a universal truth: People always need to eat. The Venture Mindset Strategy According to the principles of the Venture Mindset you don't look for steady 2% gains. You look for Moonshots where the upside is asymmetric. In the micro cap space, I am betting on a business that scales through human necessity. My Moonshot: Kimly $Kimly(1D0.SI)$ Kimly isn't just a stall. It is a massive, vertically integrated food empire in Singapore. Kimly is one of the largest traditional coffeeshop operators
Continued "Whipsaw" Volatility Expected. Monitor For ETFs and Options Play.
The situation involving the U.S.-Iran conflict is reaching a critical inflection point as of today, Wednesday, April 8, 2026. The volatility you're seeing in the markets is a direct reflection of the "deadline diplomacy" currently at play. The April 7th Deadline: Did it Shift? Yes, it effectively shifted. While President Trump initially insisted that the 8:00 PM ET deadline on April 7, 2026, was "final," he agreed to a two-week suspension of planned military strikes (specifically targeting Iran's energy infrastructure and bridges). The Catalyst: The extension came after a direct appeal from Pakistani Prime Minister Shehbaz Sharif, who is acting as a key mediator. Current Status: There is now a "double-sided ceasefire" in place for the next 14 days to allow for negotiations on a definitive
Nvidia Has Gained Some Ground After Falling For Months. What Its Chart Says Now $NVIDIA(NVDA)$ has fallen some 16% from its October high, but rebounded some 7% in recent days and is still up about 80% over the past 12 months even though it's trading lower Tuesday. Let's check out what its chart shows us. Now, I see Nvidia at a crossroads technically. It's done little more than move sideways since last July, but let's look at its daily chart going back some 14 months and running through Thursday afternoon (April 2): We will see that NVDA rallied from March 2025 until it hit a $212.19 all-time intraday high on Oct. 29. But since then, the stock has developed a descending-triangle pattern of bearish reversal